Fig. 1.
PRISMA flow diagram demonstrating study search strategy on SGLT2 Inhibitors and cardiovascular outcomes. SGLT2-I, sodium-glucose cotransporter 2 inhibitors.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.